Vraj Rangrej’s Post

We are thrilled to feature Dr. Ivy Riano, a Global Innovator & Keynote Speaker, as she presents on the critical topic of Expanding Eligibility in Lung Cancer Clinical Trials for Patients with Brain Metastasis and Leptomeningeal Disease. Link: https://t.co/jLp5TqdK0t Don't miss out on this insightful keynote hosted by MedNews Week! Shoutout to the amazing team at MedNews Week for making this event a possibility: Yan Leyfman, MD, Maduri Balasubramanian, Shreevikaa Kannan, Soumiya Nadar, Rabab Hunaid Abbas, Emad Bin Zahid, Ahmed Hashim Azeez, Vallabhaneni Sree Harshitha, Muskan Joshi,  Helena Sanchez Coloma, Harshal C., Gayathri Pramil Menon, Jade Gambill, Fabiha Amin, Adhith Theyver #OncologyResearch #CancerCare #LungCancerTrials #CancerResearch #LungCancerTrials #BrainMetastasisAwareness #LeptomeningealDiseaseAwareness #OncologyInnovation #ClinicalTrialEligibility #CancerCareAdvancements #CancerResearchCommunity #LungCancerTreatment #BrainCancerResearch#LungCancerResearch #ClinicalTrials #BrainMetastasis #LeptomeningealDisease #CancerTreatment #MedicalInnovation #OncologyCare #ExpandedEligibility #CancerAwareness #BrainCancer #LungCancerAwareness #MedicalBreakthroughs

🎗️ November is Carcinoid, Lung, Stomach, and Pancreatic Cancers Awareness Month. 🎗️ As we raise awareness for all cancers recognized this month, we join the healthcare community in advocating for early detection, innovative diagnostics, and a future where every patient receives the best possible care. At Deep Bio, we're dedicated to supporting advancements in lung cancer diagnostics through our specialized AI-driven solutions, including Lung frozen section analysis, PD-L1 IHC, and C-Met IHC. These tools provide pathologists with precision insights that can help tailor treatment and improve outcomes in lung cancer care. #CancerAwareness #LungCancer #AIinHealthcare #DigitalPathology #DeepBio #InnovationInMedicine

The approach to oncology is evolving. We’re seeing an inspiring shift as patients are no longer passive recipients of care but empowered participants throughout their entire cancer journey. This transformation is opening doors to more effective and equitable solutions for everyone touched by cancer. Join us at Inizio for an important conversation on patient centricity in cancer care at our upcoming webinar on October 8 at 3pm (BST). Sign up here: https://lnkd.in/eTUikdMe #ReimagineHealth #Oncology #CancerTreatments #InizioExpertsLive

🌍 Calling all health professionals managing patients with metastatic breast cancer 🩺 Your insights are incredibly valuable for informing the update of the Advanced Breast Cancer (ABC) Global Alliance's Global Decade Report and Global Charter. To assess the progress in advanced breast cancer over the last decade, we need your participation in two surveys designed to understand patient experiences and healthcare management. Your input will directly influence future strategies and help improve outcomes for metastatic breast cancer patients worldwide. Please take a few moments to complete the surveys and make your voice heard. Together, we can make a difference! https://ow.ly/Kb9m50SvFaL #MetastaticBreastCancer #HealthcareProfessionals #GlobalHealth #PatientCare #BreastCancerAwareness

Recognizing the Importance of Early Detection: With one in eight women expected to develop breast cancer during their lifetime, per the CDC, early detection is the key to saving lives. When discovered early, and in the localized stage, the 5-year relative survival rate for breast cancer is 99%, per the American Cancer Society. The most important screening test for breast cancer is a mammogram, an X-ray of the breast that can detect breast cancer up to two years before the tumor can be felt by you or your doctor. “Patients should start anywhere between the ages of 40 and 50 and then get mammograms on an annual basis,” advises Dr. Audrey Gonzalez, MD, a family medicine physician with STHS Clinics. To schedule a mammogram, call #STHS Pre-Registration at (956) 388-2190. For more information on mammograms, check out our latest South Texas Health Minute on ValleyCentral.com. bit.ly/3VwvKzH

We believe the patient voice should be at the heart of care. Through open communication and informed discussion, clinicians and patients can work together to make informed treatment decisions, tailored to individual needs. We are delighted to partner with the brightest minds in prostate cancer treatment and care: Professor Alison Birtle, Consultant Clinical Oncologist at The Rosemere Cancer Centre, Preston, and expert patient advocates Dr Erik Briers and Carl Guenther, members of Europa Uomo EU, to explore the power of shared decision-making in driving personalised care for people living with prostate cancer. care for people living with prostate cancer. By focusing on what matters most to each patient, we can collectively redefine care, foster stronger patient-clinician relationships, and bring more timely, targeted and effective treatments to those living with prostate cancer. Read the article: https://brnw.ch/21wP9wm #ProstateCancer #SharedDecisionMaking

The current approach to cancer care is often reactive or passive, leading to significant gaps in critical stages of the care journey. Patients are frequently left to manage care on their own, which can result in missed chances for timely interventions and adherence to evidence-based guidelines. At Color, we’ve created the nation’s first 50-state, fully-integrated Virtual Cancer Clinic to address these challenges. Watch this video to learn more. #TakeControlOfCancer

Almost all of us know someone who's gone through cancer and we wish they had more support. What if they had just completed their screening? What if they had started treatment before it spread? The what ifs never end... As an employer, you have the ability to give your people the proactive support they need to save lives and alter the course of entire families. You can do this all while being the hero who drives down major claims costs for your organization. If cancer has been a top cost driver year over year, my question is - what are you doing about it?

October is #BreastCancerAwarenessMonth—a time to shine a light on the importance of early detection, treatment innovations, and the incredible strength of survivors. We are proud to share some of the latest research and journal articles highlighting advancements in breast cancer diagnosis, therapy, and patient care. Together, through knowledge and awareness, we can support the fight against breast cancer and work toward a future without it. Increment in Oncovascular Risk Factors and Psychological Distress and Unaltered Vascular Endothelial Function with Advancement of the Stages in Newly Diagnosed Patients with Primary Breast Cancer https://lnkd.in/grr9DmDs Clinical Benefit and Safety of Palbociclib in Hormone Positive Breast Cancer with Visceral Metastasis: Real-World Experience from a Tertiary Cancer Center https://lnkd.in/gDPSZVwT #BreastCancerAwareness #ResearchMatters #HealthcareInnovation #BreastCancerResearch #SupportTheFight

While breast cancer remains far too prevalent in the U.S. and worldwide, the number of breast cancer survivors is increasing. Let's keep up the good work! With continued investment in research, better forms of detection and diagnostic tools, new treatments, and genuine, compassionate care for those facing a breast cancer diagnosis! Here in Central New York, the fight includes support of breast cancer patients with unmet financial needs -- from Saint Agatha Foundation! Whether you are a patient, a family member and caregiver, or one of our region's many medical and non-medical service providers whose clientele includes breast cancer patients, please learn more at and spread the word via: https://lnkd.in/ewDkVFWN #breastcancer #breastcancersupport #breastcancersurvivors #breastcancertreatment #breastcancertreatment #breastcancerdiagnosis #breastcancerresearch #fightbreastcancer #saintagathafoundation